Previous Page  6 / 18 Next Page
Information
Show Menu
Previous Page 6 / 18 Next Page
Page Background

Page 33

Notes:

conferenceseries

.com

Volume 8

Journal of Clinical & Experimental Pharmacology

Pharmacology and Medicinal Chemistry 2018

October 18-19, 2018

October 18-19, 2018 Dubai, UAE

International Conference on

18

th

International Conference on

&

Joint Meeting on

Pharmacology and Toxicology

Medicinal and Pharmaceutical Chemistry

Astudy of CYP2C19*2, *3 and *7 in different Sudanese ethnic groups and their response toOmeprazole

based triple therapy in Khartoum, Sudan 2016-2017

Safinaz Ibrahim Khalil

University of Medical Sciences and Technology, Sudan

Background:

Pharmaco-genetics is an important branch of pharmacology and should be applied to assist the clinical usage of

medicines which has a strong relation with enzyme activity of certain genes and alleles known through the literature. CYP2C19

is known to affect the activity of omeprazole and this will result in different responses to treatment. The commonest alleles

through the literature are CYP2C19*2 and CYP2C19*3 which vary according to different ethnicity of different populations.

Methodology:

A purposeful convenient sampling; in which patients with peptic ulcer disease and treated with omeprazole

were reviewed and the PCR is used to differentiate the CYP2C19 different alleles in patients presenting from February 2016 to

January 2017.

Results:

In the present study we investigated the distribution of three common gene variants affecting the omeprazole treatment

of peptic ulcer disease and

H. pylori

eradication namely to CYP2C19*2, *3 and *7. The CYP2C19*2 mutation was found among

all seven ethnic groups of Sudan, Arabs mostly 17 (139) followed by Darfurians 9 (139), Beja 6 (139) and Nilotes 6 (139), Nuba

5 (139) then Nubians 3 (139) and Fulani 1 (139), p=0.048 which is significant. Regarding CYP2C19*3 mutation of this allele

is found in certain ethnic groups Arabs 6 (139), Nubians 6 (139) and Nuba 2 (139), p=0.043 significant. There is no mutation

found among different Sudanese ethnic groups in CYP2C19*7. Arabs are normal homozygotes 6 (139) and Darfurians 1 (139).

Nuba 1 (139) was found to be heterozygotes in this allele p=0.038 significant. Treatment of

H. pylori

with omeprazole-based

triple therapy was used in 110 (139) and no significant correlation found with the different ethnic groups of Sudan.

Conclusion:

These data indicate that Sudanese seven ethnic groups showed activity of CYP2C19*2, CYP2C19*3 were they

took omeprazole based triple treatment and some of them showed activity to CYP2C19*7.

Biography

Safinaz Ibrahim Khalil has her expertise in evaluation and passion in improving the health and wellbeing. Her open and contextual evaluation model based on

responsive constructivists creates new pathways for improving healthcare. She has built this model after years of experience in research, evaluation, teaching and

administration both in hospital and education institutions.

drsafinaz17@gmail.com

Safinaz Ibrahim Khalil, Clin Exp Pharmacol 2018, Volume 8

DOI: 10.4172/2161-1459-C3-034